 Home > Medical News > Latest Medical News > Sansheng Guojian and Immune Onco cooperate to carry out the clinical study of Septopin combined with IMM01

Sansheng Guojian and Immune Onco cooperate to carry out the clinical study of Septopin combined with IMM01

 Last Update: 2021-04-24
 Source: Internet
 Author: User

Tags

effect tariffs china

targeted therapy breast cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On April 7, Sunshine Guojian issued an announcement stating that it has recently signed a "Combination Drug Development Cooperation Agreement" with ImmuneOnco to jointly promote the anti-HER2 monoclonal antibody ceptin (initumab) and anti-CD47 fusion protein The clinical development and commercialization of IMM01 (hereinafter referred to as "IMM01") combination therapy in China.

The cooperation will be led by 3SBio, as the research initiator, responsible for clinical plan design and clinical operation.

Cypretin (Inituzumab) is the first Fc-segment modification approved for marketing in China.

The IMM01 project for injection is a new generation of immune checkpoint inhibitors developed on the basis of ImmuneOnco’s “mAb-Trap” technology platform.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.